Product Categories
| Country: | China |
|---|---|
| Tel: | 400-400-8210725 |
| Mobile: | 17717813675 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 3',5'-Dimethyl-[1,1'-biphenyl]-4-carboxylic acid | C15H14O2 | 505082-92-8 | Details |
| n,n-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride | C15H25BClNO2 | 1036991-19-1 | Details |
| n-Benzyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | C20H26BNO2 | 1150271-53-6 | Details |
| 1-(2-(Methoxymethoxy)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C13H23BN2O4 | 1013101-73-9 | Details |
| N-Cyclohexyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | C16H26BN3O2 | 1218789-35-5 | Details |
| 1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperidine hydrochloride | C18H29BClNO2 | 1021186-08-2 | Details |
| 5,5-Dimethyl-2-(thiophen-2-yl)-1,3,2-dioxaborinane | C9H13BO2S | 355408-55-8 | Details |
| 5-Bromo-1-isopropyl-1H-indazole | C10H11BrN2 | 1280786-83-5 | Details |
| 2-(cyclooct-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C14H25BO2 | 448211-45-8 | Details |
| (2-Methyl-5-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid | C11H16BNO4S | 871333-01-6 | Details |
| Ethyl 2-chloro-4-iodopyridine-3-carboxylate | C8H7ClINO2 | 219727-21-6 | Details |
| (1-(P-tolyl)-1H-pyrazol-4-yl)boronic acid | C10H11BN2O2 | 1072945-92-6 | Details |
| 4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | C15H20BNO2 | 1072811-23-4 | Details |
| (4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl)boronic acid | C9H9BN2O3 | 913835-70-8 | Details |
| 4-Isopropoxy-3-methoxybenzoic acid | C11H14O4 | 3535-33-9 | Details |
| (2-Methyl-5-(piperidin-1-ylsulfonyl)phenyl)boronic acid | C12H18BNO4S | 871333-00-5 | Details |
| (5-(n-(Tert-butyl)sulfamoyl)-2-methylphenyl)boronic acid | C11H18BNO4S | 874219-47-3 | Details |
| (2,4,6-Trifluoro-3-propoxyphenyl)boronic acid | C9H10BF3O3 | 871125-70-1 | Details |
| 5-Bromo-2-propyl-2H-indazole | C10H11BrN2 | 1280786-77-7 | Details |
| (4-(n-(P-tolyl)sulfamoyl)phenyl)boronic acid | C13H14BNO4S | 957062-88-3 | Details |
| SIAB(N-succinimidyl (4-iodoacetyl)aminobenzoate) | C13H11IN2O5 | 72252-96-1 | Details |
| (4-Ethylcyclohex-1-en-1-yl)boronic acid | C8H15BO2 | 871329-72-5 | Details |
| (2-((Diethylamino)methyl)phenyl)boronic acid | C11H18BNO2 | 95753-24-5 | Details |
| (4-Propoxy-2-(trifluoromethyl)phenyl)boronic acid | C10H12BF3O3 | 1186482-51-8 | Details |
| 3-Methyl-1-propyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C13H23BN2O2 | 847818-80-8 | Details |
| (3-Bromo-2-butoxy-5-fluorophenyl)boronic acid | C10H13BBrFO3 | 352534-85-1 | Details |
| 4'-Methoxy-[1,1'-biphenyl]-4-carbonitrile | C14H11NO | 58743-77-4 | Details |
| (4-(Benzyl(ethyl)carbamoyl)phenyl)boronic acid | C16H18BNO3 | 913835-41-3 | Details |
| Methyltris(prop-1-en-2-yloxy)silane | C10H18O3Si | 6651-38-3 | Details |
| (2S)-Isopropyl 2-((hydroxy(phenoxy)phosphoryl)amino)propanoate (Sofosbuvir Impurity) | C12H18NO5P | 1520010-86-9 | Details |
| (4-(n-Cyclopropylsulfamoyl)-2-methylphenyl)boronic acid | C10H14BNO4S | 1217501-49-9 | Details |
| 2-Ethoxy-5-fluoro-benzaldehyde | C9H9FO2 | 5710-35-0 | Details |
| (3-(Diethylcarbamoyl)-5-nitrophenyl)boronic acid | C11H15BN2O5 | 871332-82-0 | Details |
| [1,1'-Biphenyl]-4-pentanoic acid, γ-[(4-ethoxy-1,4-dioxobutyl)amino]-α-methyl-, [S-(R*,S*)]- (9CI) | C24H29NO5 | 149709-49-9 | Details |
| (4-((3-Ethoxy-3-oxopropyl)carbamoyl)phenyl)boronic acid | C12H16BNO5 | 850568-19-3 | Details |
| (6-Bromo-3-butoxy-2-fluorophenyl)boronic acid | C10H13BBrFO3 | 1072951-88-2 | Details |
| N-(4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-1-amine | C16H25BFNO2 | 1256360-59-4 | Details |
| 1-Ethoxy-2,3-difluoro-4-iodobenzene | C8H7F2IO | 144292-42-2 | Details |
| (3-Bromo-5-butoxyphenyl)boronic acid | C10H14BBrO3 | 1072951-84-8 | Details |
| 1-[(4-Methylphenyl)sulfonyl]-1H-indole | C15H13NO2S | 31271-90-6 | Details |
| 6-Methylnaphthalene-1-carboxylic acid | C12H10O2 | 6315-19-1 | Details |
| 2-(3-Methoxyprop-1-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C10H17BO3 | 634196-63-7 | Details |
| tert-butyl 2-((4R,6R)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate (Rosuvastatin Impurity） | C13H23ClO4 | 521974-01-6 | Details |
| 5-methoxy-2-(methylthio)-1H-benzo[d]imidazole (Esomeprazole Impurity） | C9H10N2OS | 91168-31-9 | Details |
| (3-((1H-1,2,4-Triazol-3-yl)carbamoyl)phenyl)boronic acid | C9H9BN4O3 | 871333-05-0 | Details |
| 1-Bromo-2-ethoxy-4-(trifluoromethyl)benzene | C9H8BrF3O | 156605-94-6 | Details |
| 2-Bromo-4-isopropylphenol | C9H11BrO | 19432-27-0 | Details |
| N1-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-N2,N2-dimethyloxalamide (Neratinib Impurity） | C28H25ClN6O4 | 1144516-19-7 | Details |
| (3S,5S)-tert-butyl 6-chloro-3,5-dihydroxyhexanoate (Rosuvastatin Impurity） | C10H19ClO4 | 325471-28-1 | Details |
| 1-Phenylpiperazin-2-one | C10H12N2O | 90917-86-5 | Details |
| 4,5,6,7-Tetrahydro-1H-indazol-5-amine | C7H11N3 | 74197-15-2 | Details |
| (9H-Fluoren-9-yl)methyl 4-methylbenzenesulfonate | C21H18O3S | 71532-40-6 | Details |
| (2R,4R)-4-methyl-1-((R)-2-(3-methylquinoline-8-sulfonamido)-5-(3-nitroguanidino)pentanoyl)piperidine-2-carboxylic acid (Argatroban Impurity） | C23H31N7O7S | 450368-56-6 | Details |
| tert-butyl 2-((4S,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate (Rosuvastatin Impurity） | C13H23ClO4 | 521974-00-5 | Details |
| 2,3-Difluoro-1-iodo-4-methoxybenzene | C7H5F2IO | 156499-64-8 | Details |
| (3-Bromo-5-nitrophenyl)(morpholino)methanone | C11H11BrN2O4 | 941294-19-5 | Details |
| (3-Bromo-5-nitrophenyl)(piperidin-1-yl)methanone | C12H13BrN2O3 | 941294-21-9 | Details |
| (R)-isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate fumarate (Tenofovir Impurity） | C21H29N6O7P | 2055343-42-3 | Details |
| 1-(Benzofuran-4-yl)piperazine Hydrochloride (Brexpiprazole Impurity） | C12H15ClN2O | 105684-85-3 | Details |
| Methyl 2-(4-pyridyl)acetate hydrochloride | C8H10ClNO2 | 70199-68-7 | Details |
| tert-butyl 2-((4S,6R)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate (Rosuvastatin Impurity） | C13H23ClO4 | 521973-99-9 | Details |
| 4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidine-5-carboxylic acid (Rosuvastatin Impurity） | C16H18FN3O4S | 1263475-93-9 | Details |
| 3-Chloro-2-fluoro-5-(trifluoromethyl)benzyl alcohol | C8H5ClF4O | 261763-05-7 | Details |
| (3-(((Benzyloxy)carbonyl)amino)-5-nitrophenyl)boronic acid | C14H13BN2O6 | 874219-56-4 | Details |
| (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)(hydroperoxy)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (Canagliflozin Impurity） | C24H25FO7S | 2247196-28-5 | Details |
| (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-ethoxyphenyl)piperidine (Paroxetine Impurity） | C21H25NO4 | 1395408-54-4 | Details |
| 2-(5-Chloro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C12H15BClNO4 | 1073353-99-7 | Details |
| (R)-diisopropyl (((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate (Tenofovir Impurity） | C15H26N5O4P | 160616-04-6 | Details |
| 1,3-Difluoro-5-(methylsulfonyl)benzene | C7H6F2O2S | 171421-55-9 | Details |
| (3-(Benzylcarbamoyl)-5-nitrophenyl)boronic acid | C14H13BN2O5 | 871332-90-0 | Details |
| (3-(N-Cyclopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid | C17H20BNO5S | 913836-07-4 | Details |
| (4-((2-Methoxy-2-oxoethyl)carbamoyl)phenyl)boronic acid | C10H12BNO5 | 850568-24-0 | Details |
| ((2R,3S,4R,5R,6S)-6-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate (Dapagliflozin Impurity) | C23H27ClO7 | 1632287-34-3 | Details |
| (3-Fluoro-4-(methoxy(methyl)carbamoyl)phenyl)boronic acid | C9H11BFNO4 | 913835-59-3 | Details |
| (3-Chloro-5-(ethylcarbamoyl)phenyl)boronic acid | C9H11BClNO3 | 957120-49-9 | Details |
| ((2R,3R,4R,5R)-3-Acetoxy-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-2-yl)methyl acetate | C13H15FN2O7 | 10212-13-2 | Details |
| (4-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid | C15H18BNO5S | 913835-54-8 | Details |
| 2,3-Difluoro-4-methoxybenzyl alcohol | C8H8F2O2 | 886500-71-6 | Details |
| (5-(Tert-butyl)-2-ethoxyphenyl)boronic acid | C12H19BO3 | 1217501-13-7 | Details |
| (5-Carbamoyl-2-chlorophenyl)boronic acid | C7H7BClNO3 | 1150114-35-4 | Details |
| 1-Chloro-3-fluoro-2-methoxy-4-methylbenzene | C8H8ClFO | 261762-80-5 | Details |
| (4-(Methylsulfonyl)-2-(trifluoromethyl)phenyl)boronic acid | C8H8BF3O4S | 1072946-16-7 | Details |
| (3-((3-Chloropropyl)carbamoyl)phenyl)boronic acid | C10H13BClNO3 | 874288-10-5 | Details |
| (5-(((Tert-butyldimethylsilyl)oxy)methyl)pyridin-3-yl)boronic acid | C12H22BNO3Si | 173999-08-1 | Details |
| (2-(Methoxymethoxy)-5-(trifluoromethyl)phenyl)boronic acid | C9H10BF3O4 | 1256355-54-0 | Details |
| 2-(3-Bromo-4-fluorophenyl)-1,3-dioxolane | C9H8BrFO2 | 77771-04-1 | Details |
| (4-((((Benzyloxy)carbonyl)amino)methyl)phenyl)boronic acid | C15H16BNO4 | 914452-61-2 | Details |
| 3-Chloro-5-fluoro-4-hydroxybenzaldehyde | C7H4ClFO2 | 870704-13-5 | Details |
| 1-(4,6-Diamino-1,3,5-triazin-2-yl)guanidine, nitrate (1:2) (Metformin Impurity） | C4H10N10O6 | 27369-26-2 | Details |
| N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide | C14H22BNO4S | 1256359-16-6 | Details |
| 1,3-Bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione (Tofacitinib Impurity) | C29H38N10O2 | 2504210-41-5 | Details |
| 7-Chloro-1-methyl-pyrazolo[4,3-b]pyridine | C7H6ClN3 | 1057672-72-6 | Details |
| O-(2-Methoxyethyl)hydroxylamine | C3H9NO2 | 54149-39-2 | Details |
| (2-Fluoro-5-(methoxy(methyl)carbamoyl)phenyl)boronic acid | C9H11BFNO4 | 874289-59-5 | Details |
| (3-((3-Ethoxy-3-oxopropyl)carbamoyl)phenyl)boronic acid | C12H16BNO5 | 850567-28-1 | Details |
| (S)-3-((Z)-2-((1R,3aR,7aR)-1-((2R,5R,E)-5,6-Dimethylhept-3-en-2-yl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)-4-methylcyclohex-3-en-1-ol | C28H44O | 21307-05-1 | Details |
| (E)-3-(2-chloro-4-(cyclopentylamino)pyrimidin-5-yl)but-2-enoic acid | C13H16ClN3O2 | 2242625-36-9 | Details |
| Product Total： Product Page： | ||||
| 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 | ||||